<i>GBA</i> ‐associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study
Kathrin Brockmann(Oregon Health & Science University), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Sylvia Pflederer(Hertie Institute for Clinical Brain Research), Walter Maetzler(Centre Hospitalier Universitaire de Lille), Thomas Gasser(Hertie Institute for Clinical Brain Research), Claudia Schulte(School of the Art Institute of Chicago), Ann‐Kathrin Hauser(German Center for Neurodegenerative Diseases), Karin Srulijes(German Center for Neurodegenerative Diseases)
Cited by 271
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k